ADHD

Neurology·MeSH: Attention Deficit Disorder with Hyperactivity

29 drugs in development·20 companies·5 clinical trials

Drug Pipeline by Phase

Approved(19)

Drug	Company
adzenys er	Neos Therapeutics, Inc. (NEOS)
adzenys xr-odt	Neos Therapeutics, Inc. (NEOS)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	SUNSET ISLAND GROUP (SUN)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
azstarys	ZEVRA THERAPEUTICS, INC. (ZVRA)
cotempla xr-odt	Neos Therapeutics, Inc. (NEOS)
Cotempla XR-ODT	AYTU BIOPHARMA, INC (AYTU)
dextroamp saccharate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
dextroamp saccharate	ANI PHARMACEUTICALS INC (ANIP)
guanfacine	GH Research PLC (GHRS)
guanfacine	Aptinyx Inc. (APTX)
guanfacine	SUNSET ISLAND GROUP (SUN)
Jornay PM	COLLEGIUM PHARMACEUTICAL, INC (COLL)
lisdexamfetamine di	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
lisdexamfetamine di	Mylan II B.V. (MYL)
lisdexamfetamine di	Amneal Pharmaceuticals, Inc. (AMRX)
Qelbree	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Phase 3(4)

Drug	Company
centanafadine	NYMOX PHARMACEUTICAL CORP (NYMXF)
ctx-1301	Cingulate Inc. (CING)
ctx-1301 - dexmethylphenidate	Cingulate Inc. (CING)
MM-120	Definium Therapeutics Inc. (DFTX)

Phase 2(2)

Drug	Company
ABV-1505	ABVC BIOPHARMA, INC. (ABVC)
MM120	Definium Therapeutics Inc. (DFTX)

Phase 1(2)

Drug	Company
lisdexamfetamine	NYMOX PHARMACEUTICAL CORP (NYMXF)
nfc-1	AEVI GENOMIC MEDICINE, INC. (GNMX)

Preclinical(1)

Drug	Company
aevi-001	AEVI GENOMIC MEDICINE, INC. (GNMX)

Unknown(1)

Drug	Company
GeneSight	MYRIAD GENETICS INC (MYGN)

BioSniper tracks 29 drugs in development for ADHD across 20 companies.

There are 5 clinical trials targeting ADHD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.